https://wikimd.org/index.php?action=history&feed=atom&title=Prusogliptin 2026-04-26T07:11:29Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Prusogliptin&diff=6428270&oldid=prev 2025-03-05T06:27:31Z

<p>CSV import</p> <p><b>New page</b></p><div>{{Short description|A pharmaceutical drug used in the treatment of type 2 diabetes}}<br /> <br /> [[File:Prusogliptin.svg|Chemical structure of Prusogliptin|thumb|right]]<br /> <br /> &#039;&#039;&#039;Prusogliptin&#039;&#039;&#039; is a pharmaceutical drug that belongs to the class of medications known as [[Dipeptidyl peptidase-4 inhibitors|DPP-4 inhibitors]]. It is primarily used in the management of [[type 2 diabetes mellitus]], a chronic condition characterized by insulin resistance and impaired insulin secretion.<br /> <br /> ==Mechanism of Action==<br /> Prusogliptin functions by inhibiting the enzyme [[Dipeptidyl peptidase-4|DPP-4]], which is responsible for the degradation of incretin hormones such as [[glucagon-like peptide-1]] (GLP-1) and [[glucose-dependent insulinotropic polypeptide]] (GIP). These hormones play a crucial role in the regulation of glucose metabolism by enhancing insulin secretion and inhibiting glucagon release in response to meals. By preventing the breakdown of incretin hormones, Prusogliptin increases their levels in the bloodstream, thereby improving glycemic control in patients with type 2 diabetes.<br /> <br /> ==Pharmacokinetics==<br /> Prusogliptin is administered orally and is absorbed into the bloodstream, where it exerts its effects on the DPP-4 enzyme. The drug has a favorable pharmacokinetic profile, with a long half-life that allows for once-daily dosing. It is metabolized in the liver and excreted primarily via the kidneys.<br /> <br /> ==Clinical Use==<br /> Prusogliptin is indicated for the treatment of type 2 diabetes in adults. It is often used in combination with other antidiabetic agents such as [[metformin]] or [[sulfonylureas]] to achieve better glycemic control. The drug is particularly beneficial for patients who are unable to achieve adequate blood sugar levels with lifestyle modifications and other medications alone.<br /> <br /> ==Side Effects==<br /> Common side effects of Prusogliptin include [[nasopharyngitis]], [[headache]], and [[upper respiratory tract infection]]. Like other DPP-4 inhibitors, it is generally well-tolerated, but there is a potential risk of [[pancreatitis]] and [[hypersensitivity reactions]]. Patients should be monitored for signs of these adverse effects during treatment.<br /> <br /> ==Contraindications==<br /> Prusogliptin is contraindicated in patients with a history of serious hypersensitivity to the drug or any of its components. Caution is advised in patients with severe renal impairment or a history of pancreatitis.<br /> <br /> ==Related pages==<br /> * [[Type 2 diabetes mellitus]]<br /> * [[Dipeptidyl peptidase-4 inhibitors]]<br /> * [[Glucagon-like peptide-1]]<br /> * [[Metformin]]<br /> <br /> [[Category:Antidiabetic drugs]]<br /> [[Category:Dipeptidyl peptidase-4 inhibitors]]</div>

Prab